Company intelligence / Profile preview

Radforsk

Oslo, Norway

Ownership: Private
Development stage: Other

Overview

Radforsk is an evergreen oncology-focused investment and innovation foundation that commercializes cancer research from Oslo University Hospital and other academic institutions, building and financing companies and infrastructure such as Oslo Cancer Cluster and Oslo Cancer Cluster Innovation Park to develop new cancer diagnostics and treatments.[1][2][3][7][9]

Therapeutic areas: Oncology
Modalities: Small moleculeMonoclonal antibodyAntibody-drug conjugateVaccineCell therapyCAR-T cell therapyGene therapyRadiopharmaceuticalBiologicRNA therapy
Industry: Investors

Partnerships

Oslo University HospitalNorwegian Radium Hospital (part of Oslo University Hospital)Oslo Cancer ClusterOslo Cancer Cluster IncubatorOslo Cancer Cluster Innovation ParkThermo Fisher Scientific (as a major tenant/partner in the expanded Innovation Park)[3]

Beyond the preview

Go deeper on Radforsk.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Radforsk.

Explore the full profile